Skip to main content
Clinical Trials/CTRI/2023/06/053622
CTRI/2023/06/053622
Not yet recruiting
Phase 2

A Comparative clinical study on the efficacy of Laooq shamoon vs Laooq khiyarshambar in Allergic Rhinitis

ational Institute of Unani Medicine Bangalore0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: J309- Allergic rhinitis, unspecified
Sponsor
ational Institute of Unani Medicine Bangalore
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
ational Institute of Unani Medicine Bangalore

Eligibility Criteria

Inclusion Criteria

  • 1\.Age between 18\-60 years
  • 2\. All genders
  • 3\. All cases of allergic rhinitis according to ARIA classification
  • 4\. Subjects with both intermittent and/or persistent allergic rhinitis and having at least two of the following rhinitis\-associated conditions: nasal congestion, rhinorrhea, sneezing and nasal itching.
  • 5\. Patients who will give consent and able to do follow up

Exclusion Criteria

  • 1\. Subjects having Nasal polyps, Sinusitis, Atrophic rhinitis, Hypertrophied turbinates,Deviated nasal septum, and congenital nasal abnormalities like nasal dermoid cysts,
  • congenital midline nasal masses etc.
  • 2\. Subjects with a history of heart diseases, kidney diseases, liver diseases, DM,Malignancy, and severe asthma.
  • 3\. Subjects who had received systematically or topically administered corticosteroids,
  • antihistamines, or decongestants 07 days prior to enrolment
  • 4\. Personnel who are taking part in other clinical trials
  • 5\. Subjects with known allergy from the ingredients of trial interventions
  • 6\. Pregnant and lactating women

Outcomes

Primary Outcomes

Not specified

Similar Trials